BioCentury | Feb 20, 2021
Product Development

BMS turns to mechanistic diversity in early oncology pipeline

...values reaching $3.07 billion for the 2020 target discovery...
BioCentury | Jan 27, 2021
Product Development

KSQ sets sights on the clinic as new CEO steps in

...KSQ plans to advance its first cancer program emerging from its CRISPR-based target discovery platform into the...
...is setting a path to advance targeted oncology and immuno-oncology programs emerging from its CRISPR-based target discovery...
BioCentury | Jan 12, 2021
Finance

Jan. 11 Quick Takes: Megarounds for Valo, Visen; plus NuProbe, Sensei

...company debuted in September with a cloud-computing platform that is geared to guide everything from target discovery...
BioCentury | Dec 31, 2020
Finance

Dec. 30 Quick Takes: Transcenta leads year-end crop of China venture rounds

...company will use the financing to support development of its immunoprofiling platform for precision medicine, target discovery...
BioCentury | Dec 23, 2020
Deals

Insilico caps year of deals by opening its computational platforms to pharmas’ in-house teams

...discovery, and came with undisclosed upfront and milestone payments; the other two were focused on target discovery...
...January, the company will unveil an internal program that used Pandaomics and Chemistry42 to go from target discovery...
...deal valued at up to $200 million. Flagship-built Valo Health LLC is also combining computational target discovery...
BioCentury | Dec 22, 2020
Deals

Flagship’s Valo seeks cancer-like approach to CV drug development with G3 partnership

...Editor Valo’s partnership with G3 sheds more light on the Flagship Pioneering-built company’s in silico target discovery...
BioCentury | Oct 23, 2020
Product Development

What’s next for targeted protein degradation

...also increasingly being used as tools for target discovery...
BioCentury | Sep 25, 2020
Product Development

Flagship’s Valo takes stab at cloud-based R&D with $96.5M and longitudinal human data

...test with Valo Health LLC, whose cloud computing platform is geared to guide everything from target discovery...
...“the skeleton of a closed loop” strategy, Berry said.According to Berry, Valo’s Opal platform guides target discovery...
BioCentury | Jun 17, 2020
Deals

With Ideaya deal, GSK bulks up synthetic lethality side of oncology business

...space. Last June, GSK CSO and President of R&D Hal Barron told BioCentury synthetic lethality target discovery...
BioCentury | May 27, 2020
Deals

Sanofi's sale of Regeneron stake for $11B could set stage for both companies' growth through M&A

...via its genetic research, with deal structures that can leverage its expertise in antibody and target discovery...
Items per page:
1 - 10 of 354
BioCentury | Feb 20, 2021
Product Development

BMS turns to mechanistic diversity in early oncology pipeline

...values reaching $3.07 billion for the 2020 target discovery...
BioCentury | Jan 27, 2021
Product Development

KSQ sets sights on the clinic as new CEO steps in

...KSQ plans to advance its first cancer program emerging from its CRISPR-based target discovery platform into the...
...is setting a path to advance targeted oncology and immuno-oncology programs emerging from its CRISPR-based target discovery...
BioCentury | Jan 12, 2021
Finance

Jan. 11 Quick Takes: Megarounds for Valo, Visen; plus NuProbe, Sensei

...company debuted in September with a cloud-computing platform that is geared to guide everything from target discovery...
BioCentury | Dec 31, 2020
Finance

Dec. 30 Quick Takes: Transcenta leads year-end crop of China venture rounds

...company will use the financing to support development of its immunoprofiling platform for precision medicine, target discovery...
BioCentury | Dec 23, 2020
Deals

Insilico caps year of deals by opening its computational platforms to pharmas’ in-house teams

...discovery, and came with undisclosed upfront and milestone payments; the other two were focused on target discovery...
...January, the company will unveil an internal program that used Pandaomics and Chemistry42 to go from target discovery...
...deal valued at up to $200 million. Flagship-built Valo Health LLC is also combining computational target discovery...
BioCentury | Dec 22, 2020
Deals

Flagship’s Valo seeks cancer-like approach to CV drug development with G3 partnership

...Editor Valo’s partnership with G3 sheds more light on the Flagship Pioneering-built company’s in silico target discovery...
BioCentury | Oct 23, 2020
Product Development

What’s next for targeted protein degradation

...also increasingly being used as tools for target discovery...
BioCentury | Sep 25, 2020
Product Development

Flagship’s Valo takes stab at cloud-based R&D with $96.5M and longitudinal human data

...test with Valo Health LLC, whose cloud computing platform is geared to guide everything from target discovery...
...“the skeleton of a closed loop” strategy, Berry said.According to Berry, Valo’s Opal platform guides target discovery...
BioCentury | Jun 17, 2020
Deals

With Ideaya deal, GSK bulks up synthetic lethality side of oncology business

...space. Last June, GSK CSO and President of R&D Hal Barron told BioCentury synthetic lethality target discovery...
BioCentury | May 27, 2020
Deals

Sanofi's sale of Regeneron stake for $11B could set stage for both companies' growth through M&A

...via its genetic research, with deal structures that can leverage its expertise in antibody and target discovery...
Items per page:
1 - 10 of 354